[Tickers Inside] 7 Solid Gainers Over the Last 5 Sessions

Stocks with 5 days of consecutive price advances. If you cannot see this email properly, please click [here]( [62b0e3d54029...] --------------------------------------------------------------- [Biden Warns America on China: "They're Going to Eat Our Lunch"]( [Find out what you need to know in this report.]( --------------------------------------------------------------- August 16, 2022 From the desk of the Editor (5 Day Gainers Report) Dear Reader, We just identified 7 Five Day Gainers of all US Exchanges. If you are interested in any of these companies, we encourage you to do your own research and due diligence. Keep reading to see what we just uncovered... --------------------------------------------------------------- [The WORST National Security Threat To The USA Since The 1973 Arab Oil Embargo?]( [3f00c978-908...](Communist China has the USA in a resource stranglehold. They have a monopoly on this CRITICAL metal that we desperately need for military technology. In fact, both Trump AND Biden passed executive orders that addressed this crisis. And it could have a massive effect on smart investor's bank accounts. [See This Growing National Security Threat Here]( [5381a560-c43...]([aff_i?offer_...] --------------------------------------------------------------- [FlexShopper, FPAY]( Recent Analyst Action: Michael Diana, analyst at Maxim Group, reiterates coverage on [FlexShopper (FPAY)](in the Financial sector with a Buy rating and a price target of $2.5 (4 days ago). - Recent Price: $$2.7 - Average Analyst Price Target: $3.25 (20.37%) - Market Cap: $$49.69M [TipRanks.com]( also reports that [FlexShopper](currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $3.25. The target pricing ranges from a high forecast of $4.00 down to a low forecast of $2.50. [FlexShopper (FPAY)](’s last closing price was $2.7 which would put the average price target at $3.25. Here are 3rd party ratings for [FPAY](: - TipRanks.com: Moderate Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Strong Buy, Bottom 33% (168 out of 252) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [ALERT: Sell these found funds today]( If you own funds from Fidelity, iShares or Franklin Templeton, you may have a ticking time bomb sitting in your portfolio. [Read this urgent briefing to see why this could set your retirement back ten years!]( [5381a560-c43...]( [aff_i?offer_...] --------------------------------------------------------------- [Terns Pharmaceuticals, TERN]( Recent Analyst Action: Eric Joseph, analyst at J.P. Morgan, reiterates coverage on [Terns Pharmaceuticals (TERN)](in the Healthcare sector with a Hold rating and a price target of $5 (1 week ago). - Recent Price: $$4.81 - Average Analyst Price Target: $5.00 (3.95%) - Market Cap: $$165.50M [TipRanks.com]( also reports that [Terns Pharmaceuticals](currently has 1 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $5.00. The target pricing ranges from a high forecast of $5.00 down to a low forecast of $5.00. [Terns Pharmaceuticals (TERN)](’s last closing price was $4.81 which would put the average price target at $5.00. Here are 3rd party ratings for [TERN](: - TipRanks.com: Hold - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: buy - Zacks.com: Buy, Top 27% (69 out of 252) [Click here for chart >>]( -------------------------------------------------------------------------- [Vacasa, VCSA]( Recent Analyst Action: Eric Sheridan, analyst at Goldman Sachs, reiterates coverage on [Vacasa (VCSA)](in the Financial sector with a Hold rating and a price target of $6 (5 days ago). - Recent Price: $$5.5 - Average Analyst Price Target: $7.50 (36.36%) - Market Cap: $$2.59B [TipRanks.com]( also reports that [Vacasa](currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $7.50. The target pricing ranges from a high forecast of $10.00 down to a low forecast of $6.00. [Vacasa (VCSA)](’s last closing price was $5.5 which would put the average price target at $7.50. Here are 3rd party ratings for [VCSA](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: n/a - Zacks.com: Buy, Bottom 44% (141 out of 252) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [Account Taken a Beating This Year? Hear What This 20-Year Floor Trading Phenom Is Doing for People Like You]( [33474e49-82f...](Andrew Keene has been absolutely crushing it in 2022. Bull market, bear market, sideways market… It doesn’t matter to Andrew. Because he’s found a way to get the inside scoop on what the big money market movers are doing with their money… And pass those signals on to you, in REAL TIME. One hour is all he’s needed to signal gains of 60%, 130%, even 180% from this method. And for the first time ever, he’s opening enrollment for everyday traders like you to join him. [Click here for your chance to join before the room fills up.]( [5381a560-c43...]( [aff_i?offer_...] --------------------------------------------------------------- [Veru, VERU]( Recent Analyst Action: Yi Chen, analyst at H.C. Wainwright, reiterates coverage on [Veru (VERU)](in the Healthcare sector with a Buy rating and a price target of $24 (4 days ago). - Recent Price: $$23.52 - Average Analyst Price Target: $30.25 (28.61%) - Market Cap: $$1.57B [TipRanks.com]( also reports that [Veru](currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $30.25. The target pricing ranges from a high forecast of $36.00 down to a low forecast of $24.00. [Veru (VERU)](’s last closing price was $23.52 which would put the average price target at $30.25. Here are 3rd party ratings for [VERU](: - TipRanks.com: Strong Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Bottom 41% (149 out of 252) [Click here for chart >>]( -------------------------------------------------------------------------- [Enovix, ENVX]( Recent Analyst Action: Gus Richard, analyst at Northland Securities, reiterates coverage on [Enovix (ENVX)](in the Industrial Goods sector with a Buy rating and a price target of $25 (5 days ago). - Recent Price: $$25.98 - Average Analyst Price Target: $22.50 (-13.39%) - Market Cap: $$3.89B [TipRanks.com]( also reports that [Enovix](currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $22.50 . The target pricing ranges from a high forecast of $25.00 down to a low forecast of $20.00. [Enovix (ENVX)](’s last closing price was $25.98 which would put the average price target at $22.50. Here are 3rd party ratings for [ENVX](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: buy - Zacks.com: Hold, Top 27% (69 out of 252) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- ["White Gold" is the New Oil]( [65f96598-96d...](The green revolution is here and creating a massive demand for this critical material. However, China has almost total control of the world's supply. And one under the radar company is poised to break that stranglehold. For investors, the time is now. [Read this free report before it gets the attention of Wall Street.]( [5381a560-c43...]( [aff_i?offer_...] --------------------------------------------------------------- [Navitas Semiconductor, NVTS]( Recent Analyst Action: Quinn Bolton, analyst at Needham, reiterates coverage on [Navitas Semiconductor (NVTS)](in the Technology sector with a Buy rating and a price target of $8 (12 hours ago). - Recent Price: $$7.57 - Average Analyst Price Target: $8.00 (5.68%) - Market Cap: $$761.94M [TipRanks.com]( also reports that [Navitas Semiconductor](currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $8.00. The target pricing ranges from a high forecast of $12.00 down to a low forecast of $5.00. [Navitas Semiconductor (NVTS)](’s last closing price was $7.57 which would put the average price target at $8.00. Here are 3rd party ratings for [NVTS](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Sell, Bottom 47% (133 out of 252) [Click here for chart >>]( -------------------------------------------------------------------------- [Genprex, GNPX]( Recent Analyst Action: Robert LeBoyer, analyst at Noble Financial, reiterates coverage on [Genprex (GNPX)](in the Healthcare sector with a Buy rating and a price target of $5 (7 months ago). - Recent Price: $$2.33 - Average Analyst Price Target: $5.00 (114.59%) - Market Cap: $$100.11M [TipRanks.com]( also reports that [Genprex](currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $5.00. The target pricing ranges from a high forecast of $5.00 down to a low forecast of $5.00. [Genprex (GNPX)](’s last closing price was $2.33 which would put the average price target at $5.00. Here are 3rd party ratings for [GNPX](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Hold, Top 27% (69 out of 252) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [Potential Gold Rush For Investors Sparked By USA Vs. China Trade War]( [b16d0c0a-3f9...](Right now, China has the US Military in a stranglehold. They hold a monopoly on one of our most CRITICAL defense elements. But thanks to executive orders from both Biden and Trump... China's Monopoly Is About To Crumble... [And Create A Potential Boom For Investors]( [5381a560-c43...]( [aff_i?offer_...] --------------------------------------------------------------- And there you have it--7 Five Day Gainers of all US Exchanges. Sincerely, Editor, MarketInsidersPress.com Market Insider Press Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. MarketInsidersPress.com Sandpiper Marketing Group, LLC | | PO Box 407 | Mount Mourne | | North Carolina | 28123 | | United States | 8458030954 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software